DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has one hundred and sixteen approved drugs.
There are twenty-two tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 0 |
| Tradenames: | 103 |
| Ingredients: | 101 |
| NDAs: | 116 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 079187-003 | May 27, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 091502-001 | Nov 9, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | ITRACONAZOLE | itraconazole | CAPSULE;ORAL | 200463-001 | Jul 20, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | MALATHION | malathion | LOTION;TOPICAL | 078743-001 | Mar 6, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | DICLOFENAC SODIUM | diclofenac sodium | TABLET, DELAYED RELEASE;ORAL | 075281-003 | Feb 12, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 073144-003 | Mar 25, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | Start Trial |
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
